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ABSTRACT
Goal: The goal of this Service Learning/Capstone Experience is to provide an in-depth
policy analysis and interpretation of the 2018 proposed changes in the Quality Payment
Plan (QPP) as part of the 2015 MACRA legislation for the purpose of developing
organizational training material.
Objectives: The key objectives of this project are 1) to complete a policy review of the
current and proposed Quality Payment Program legislation from the Centers for
Medicare and Medicaid Services (CMS), including June 2017 proposed updates and the
November 2017 final rule updates; 2) to gain physician and hospital administrator’s
perspective on realized and perceived impact of the ruling; and 3) to develop a robust
educational training plan focused on integrating the updated Quality Payment Program
into Medtronic’s Health Care Economics’ team, giving them the appropriate tools to
facilitate meaningful partnerships with external customers.
Methods: Policy analysis of the 2018 changes to CMS’s MACRA legislation will be
conducted as a major component of this Service Learning and Capstone Experience.
Additionally, the impact of the shift from volume to value measures in physician
payment models will be explored through interviews, physician panels and advisory
board surveys. The Value Based Health Care Team utilizes educational resources
developed in 2015 that support the initial launch of the Quality Payment Program, which
will be reviewed in-depth. Using the data obtained from these activities, a needs
analysis will be performed to identify key training and education components that will
need to be addressed by the Value Based Health Care team.
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Impact: Medtronic defines value-based health care as “an effort to develop and deploy
products, services and integrated solutions that improve patient outcomes per dollar
spent in the healthcare system by improving the quality of care and or reducing the
associated expense” (Medtronic, 2017). As a major component of this effort, Medtronic
has developed strategies to align outcomes with health care delivery and payment
systems (Medtronic, 2017). For Medtronic to understand how the impact of the 2018
QPP updates fits into this strategy, it is critical for the health care economics and policy
team to have a robust and cohesive educational plan. Interpreting the current
legislation, as well as proposed updates will be a key initiative for this team to effectively
partner with physicians and hospital administrators.
INTRODUCTION
Service Learning Placement Site Organization
Medtronic, Inc
Mission and Aim of the Organization:
Medtronic is a global healthcare solutions company committed to improving the lives of
people through our medical technologies, services, and solutions.
The Medtronic Mission: “Since 1960, our Mission reminds us that our foremost priority is
to contribute to human welfare. For more than 50 years, it has provided an ethical
framework and inspirational goal for Medtronic employees around the world.”
“Our Mission guides our day-to-day work and reminds us that our efforts, large and
small, transform the lives of millions of people each year. Over time, and no matter what
we do, our Mission remains the same —To contribute to human welfare by application
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of biomedical engineering in the research, design, manufacture, and sale of instruments
or appliances that alleviate pain, restore health, and extend life.”
Medtronic began as an electronic medical device company in the Twin Cities and has
grown and evolved into an industry leader in global healthcare solutions. Medtronic
designs, develops and manufactures diagnostic and therapy devices for nearly every
part of the human body, as well as data management and other solutions-based
products and services.
Within Medtronic, the Value Based Healthcare group works to analyze health policy,
study and track global healthcare trends, and advance business strategies that align
with VBHC initiatives. “Value-based healthcare (VBHC) has become an important part
of the global healthcare arena. The world and Medtronic are evolving to VBHC and we
are deeply invested in accelerating its adoption worldwide. The concept of VBHC aligns
with our business strategy and helps advance our commitment to take healthcare
Further, Together” (Medtronic, 2017).
Problem Statement
The Value Based Healthcare Team within Medtronic has a strong need to provide
updated training and education on the newly updated Quality Payment Plan that was
proposed in June 2017 and finalized in November 2017, as part of the larger MACRA
legislation.
Experience and Context
Since the passing of the Medicare Access and CHIP Reauthorization Act (MACRA) in
2015, physicians, payers, hospital administrators and health care solutions
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organizations have been closely studying the impact of transitioning the fee-for-service
model of reimbursement to a quality and outcomes-based approach. Aggressive yet
achievable timelines have been set by the US Department of Health and Human
Services to link “85 percent of traditional Medicare provider payments to quality or value
by the end of 2016, and 90 percent by the end of 2018” (Medtronic, 2017). This
process was well documented by CMS and provided a timeline for physicians and
practices to transition to one of two tracks within the QPP model: either the Advanced
Alternative Payment Model (APM) or the Merit-based Incentive Payment System (MIPS)
(CMS, 2017). January 1, 2017 marked the beginning of the first year of participation,
and reporting for the results of the 2017 calendar year will occur in the first 3 months of
2018. The results will be processed through 2018, and will impact the payment
structure for 2019, depending on if the performance metrics are achieved or not (CMS,
2017). Considering the transition to this new system is in the early stages, there is a
measure of uncertainty related to how physicians and other providers will be impacted
in a long-term setting.
As a health care solutions organization, Medtronic seeks to integrate increased efforts
to implement value across all therapy platforms, using the concept of “economic value”
which was integrated into the company’s operating procedures in 2012. This focused
effort ensured that any product or service offered by Medtronic provided not only clinical
or therapy benefit, but also a measure of economic benefit. A few recent examples of
this strategy include increased efficiency in care delivery, reduction of system waste and
expanding patient access (Medtronic, 2015). “At Medtronic, we believe that our
technologies, the data and insights they create, and our expertise can be combined in
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partnership with hospitals, payers and governments to help establish aligned, valuebased healthcare models that can deliver better patient outcomes- while maintaining or
reducing costs” (Medtronic, 2015). This intensive, company-wide focus on economic
value requires close monitoring and understanding of policy initiatives related to shifting
health care to a value-based model.
Goals and Objectives
1. Goal: To provide an in-depth policy analysis and interpretation of the 2018 proposed
and finalized changes in the Quality Payment Plan (QPP) as part of the 2015 MACRA
legislation and develop organizational training material.
a. Objective #1: To complete a policy review of the current and proposed Quality
Payment Program legislation from the Centers for Medicare and Medicaid
Services (CMS), including June 2017 proposed and November 2017 finalized
updates.
i. Activity #1: Conduct a legislation and policy review of the 2015 MACRA
legislation and accompanying 2018 proposed and final rules.
ii. Activity #2: Conduct a program gap analysis related to the impact of
QPP legislation on Medtronic’s Value Based Health Care initiatives.
b. Objective #2: To gain physician and hospital administrator perspectives on
realized and perceived impact of the ruling and how they are implementing
changes in their practice.
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i. Activity #3: Conduct interviews


Medtronic Health Policy, Economics & Reimbursement Specialist



Washington Health Policy Fellow



Medtronic’s external consultation partner

ii. Activity #4: Attend and observe a physician panel discussion
iii. Activity #5: Attend and observe a healthcare economics and hospital
administrator’s advisory board meeting(MDAP)


Provide planning and logistical support
o Create individual presentation packets for attendees and
presenters
o Distribution and tabulation of attendee surveys using the
Qualtrics survey tool to identify key themes and trends in
participant responses

iv. Activity #6: Attend and observe the Hospital Administrator’s Advisory
Meeting


Provide planning and logistical support

c. Objective #3: To develop a robust educational training plan focused on
integrating the updated Quality Payment Program into Medtronic’s Health Care
Economics’ team.
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i. Activity #7: Conduct a gap analysis of Medtronic’s current training plan
for MACRA to determine what areas of focus should be identified for
future training and education
ii. Activity #8: Create and distribute surveys using Qualtrics survey tool to
identify training needs and identify areas of focus for additional
educational development
ii. Activity #9: Develop supplemental training materials to support policy
implementation
Application of Public Health Competencies
*See Appendix A for table
Core/Cross-Cutting Competencies
4.A. – Health Policy and Management: Identify the main components and issues of the
structure, financing, and delivery of health services within the health systems in
the U.S.
8.A. – Leadership, Advocacy and Community-Building: Identify linkages with key
stakeholders.
8.C. – Engage in collaborative problem-solving and decision making.
Public Health Practice Concentration Competencies
2.C – Evaluation of Programs and Interventions: Apply evaluation findings to programs
and policies.
3.A. – Strategic Planning: Evaluate and document internal and external strengths,
weakness, opportunities and threats to identify strategic issues.
3.C – Strategic Planning: Demonstrate the skills to lead and facilitate planning activities.
3. D. Demonstrate the skills to implement operational and strategic plans, evaluating
performance and adjusting implementation activities and/or plans.
Literature Review
MACRA Legislation:
In 2015, the Medicare Access and CHIP Reauthorization Act (MACRA) legislation was
passed by the US Congress, with the aim of transitioning physician reimbursement from
a fee-for-service to a value-based approach. The beginning of the measuring and
reporting period was January 2017, and updates to the legislation were proposed in

Page | 8

SL/CE Final Paper – Katie Joseph Johnson

June 2017 and are expected to be finalized in November of 2017 (CMS, 2016),
(Medtronic, 2017). “MACRA has dramatic implications for all US based healthcare
providers. MACRA permanently repealed the Medicare Sustainable Growth Rate to
stabilize physician Part B Medicare payments, consolidated pre-existing federal
performance programs into the Merit based Incentive Payments System (MIPS), and
legislatively mandated new approaches to paying clinicians” (Hirsch et al., 2016).
As part of the MACRA legislation, the QPP (Quality Payment Program) has two arms
that focus on different aspects of cost reduction and improved quality outcomes: 1)
Advanced Alternative Payment Models and 2) Merit based Incentive Programs (MIPS).
Table 1: QPP Strategic Goals
Quality Payment Program Strategic Goals
Improve beneficiary outcomes

Enhance clinician experience

Increase adoption of Advanced APMs

Maximize participation

Improve data and information sharing

Ensure operational excellence in program
implementation

(CMS, 2016)
The APM model focuses on innovative payment structures and the MIPS program
focuses on adjusting payments based on performance-based outcomes. The 2017
QPP program includes providers (physicians, physician’s assistants, nurse practitioners,
clinical nurse specialists, and Certified Registered Nurse Anesthetists) who meet the
criteria for 2017: those who are already participating in an Advanced APM, or “who
currently bill Medicare Part B over $30,000 per year with more than 100 Medicare
patients per year”, (CMS: QPP, 2017).
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Providers who choose the MIPS Quality Performance Category will submit specific
measures which will be compared to established benchmarks and will receive points on
a scale from 3-10. “Benchmarks are specific to the type of submission mechanism:
EHFs, QCDRs/Registries, CAHPS and claims”, (CMS: QPP, 2017). Within the
benchmark categories, providers can select the measure(s) that are most relevant to
their own practice. Points are earned on a 100-point scale, at which a score of >70
points denote exceptional performance (positive payment adjustment and potential
bonus payments), 4-69 points denotes positive performance (positive payment
adjustment), 3 points denotes neutral performance (no change to payment adjustment)
and 0 points denotes non-participation (negative payment adjustment), (CMS, 2016).
Advanced APM’s include such initiatives as the Medicare Shared Savings Program,
CMS Innovation Center models, Accountable Care Organizations (ACO’s), PatientCentered Medical Homes and Bundled Payments, (Teferi et al., 2016). The APM
scoring system utilizes a weighted scoring system across the domains of Quality, Cost,
Improvement Activities and Advancing Care Information, with a focus of incentivizing
payments based on innovation and value, (CMS, 2016).
Anticipated Impact:
After the original 2015 legislation was passed, many physicians’ advocacy groups and
healthcare analysts began the process of understanding how the law would be
implemented, as well as how it would impact physician (and other provider’s)
reimbursement and practice standards. CMS developed a dedicated website to the
QPP, providing education and resources in the lead-up to the 2017 reporting year
(CMS, 2016). Many physician advocacy groups and industry analysts have focused
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attention on directing training towards the repeal and replacement of the Sustainable
Growth Rate formula, acknowledging that this shift will impact specific types of providers
differently, (Apte & Patel, 2016; Hirsch et al., 2016; CMS, 2016). The literature
suggests consensus that replacing SGR is a positive step, but still leaves uncertainty for
the stability of physician payments in the long-term. “The SGR is gone, but there is no
permanent fix for physician payments”, (Oberlander & Laugesen, 2015).
There has been a varied response from physician groups depending both on the type of
practice (example; interventional pain management versus surgical oncology) and the
geographic region, (Manchikanti et al., 2016), (Apte & Patel, 2016), (Sayeed et al.,
2017), (Teferi et al., 2016). Various physician advocacy groups have identified
anticipated benefits of QPP elements which include increased opportunity for bonus
payments and higher rewards for demonstrated quality and cost-reduction, a lower
administrative burden through the streamlining of several previous quality initiatives,
alignment of previously fragmented or poorly coordinated care and standardization of
quality measures, (Teferi et al, 2016), (Apte & Patel, 2016) and (Machikanti et al.,
2017). Other literature calls out some remaining challenges and skepticism, such as
the costly and complicated EHR integration, level of intensity for reporting for
practitioners, and issues with understanding and selecting appropriate benchmark
measures, (Manchikanti et al., 2016), (Teferi et al, 2016) and (Hirsch et al., 2017).
The goals of QPP, which include a more standardized approach to performance
outcomes and simplification of reporting, are generally met with positive reception in the
literature, whereas the feasibility and implementation are met with significant
challenges, (Chen & Coffron, 2017), (Hirsch et al., 2017). “Surgeons should be taking
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steps now to ensure that they are prepared to succeed in the QPP. The transition
period creates a clear pathway for avoiding penalties while providing an opportunity to
test one’s ability to participate and improve performance”, (Chen & Coffron, 2017).
METHODS
The issue defined in this SL/CE is related to how physician payment models impact the
structure and nature of interactions between Medtronic and collaborative partners, such
as payers, physicians and hospital administrators. The nature of this SL/CE is based in
policy analysis and program development, rather than quantitative research methods.
Therefore, the methods used in this project are distinctly practical in nature.
Defined Research Question: What training and education is needed for care providers
to understand the impact and implications of the 2018 Updates to the MACRA
legislation on physician payment models? Additionally, we will examine what factors
are driving the decision of providers to choose one facet of the QPP over the other
(MIPS versus APMS) and how the medical technology industry can partner with
healthcare providers to ensure value and reduced healthcare costs.
Application of Theories/Theoretical Models: Not applicable
Study Design: Advisory Board meetings will utilize needs-assessment and gap-analysis
surveys. The Qualtrics survey tool will be administered to identify themes and trends in
participant responses related to QPP elements and implementation.
Sample Size: Advisory board meetings will include approximately 50 participants from a
representative sample of US states/regions, and from varying practice volumes.
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Data Sources: Centers for Medicare and Medicaid Services’ Quality Payment Program,
Medtronic’s Value Based Health Care program team, US Department of Health and
Human Services, and peer-reviewed literature obtained from the UNMC on-line journal
library and from Medtronic’s internal resource library.
Data Collection Tools: Physician and Hospital Advisory board meetings will include
surveys with a mix of quantitative and qualitative data.
Statistical and/or Analytical Methods: Content analysis will be performed on qualitative
data obtained from the Advisory Board surveys to identify gaps, patterns and/or new
insights.
Limitations: The Quality Payment Program (QPP) is poised to make a significant impact
on how physicians are reimbursed in the coming year. Ideally, a large sample of
physicians from around the US would be included in the research and information
gathering related to outcomes from the shift to the QPP. Time and resources are
limitations to this effort, and therefore a smaller group will be included in the feedback
gathering. Additionally, payment structures may have varying effects on different types
of physician specialties and modalities. The current structure and window of time for
this project only allow for a small sample of data to be collected during advisory boards
and will not include all possible physician specialties. Further investigation and
literature review will be conducted to address potential gaps in this area.
Policy Analysis, Interventions, and Program Development Recommendations: Policy
analysis is a major component of this SL/CE. Results from the analysis, feedback
gathering from advisory boards, and individual interviews will form the basis for
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educational program development recommendations. Current education and training
resources related to MACRA and QPP will be revised as necessary to align with the
updated QPP proposed rule, and new educational materials will be developed based on
findings from this SL/CE. Medtronic as a corporate entity, as well as its individual
business units maintain constant interface with physicians and hospital administrators
as customers as well as collaborative partners. It is critical that new policy and
legislation related to changes in the physician payment structure are clearly understood
by Medtronic to keep these interactions relevant and productive. Program development
that aligns with policy analysis findings supports this need.
RESULTS
Results presented from data collection and analysis during this project are organized
according to the defined project goals and objectives, as well as specific Service
Learning and Capstone Experience activities performed. Program evaluation findings
are presented within the model of the CDC’s “Framework for Public Health Program
Evaluation”, (CDC, 1999). Outcomes from this Service Learning and Capstone
Experience were developed utilizing the six-step approach to program evaluation,
though not all steps were conducted in a linear manner. Medtronic’s education program
for field employees and external customers who need information related to MACRA
and QPP were evaluated using the following steps as defined by the CDC, and then
mapped to Service Learning/Capstone Experience activities:
1. Engage stakeholders
a. Hospital Administrator’s Advisory Panel
b. Medical Director and Healthcare Economics Panel
c. Health Economics team conference calls
2. Describe the program
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3.
4.

5.
6.

a. Policy analysis
b. Health Economics and Reimbursement education database and materials
review
Focus the evaluation design
a. Gap analysis
Gather credible evidence
a. Surveys
b. Stakeholder interviews
Justify conclusions
a. Align recommendations to Defined Research Question(s)
Ensure use and share lessons learned
a. Distribute findings through appropriate organizational channels
b. Internal and external customers, and consistent through business units

Policy Review/Interpretation
MACRA legislation was updated during the Service Learning/Capstone Experience
period. The “Calendar Year 2018 Updates to the Quality Payment Program” effective
date was January 1, 2018, (CMS, 2017). These changes also include a comment
period to enable stakeholders to provide feedback which will help shape and evolve the
program as it moves forward. This continuous feedback loop allows the QPP to remain
dedicated to its stated intent to be “flexible, transparent, and structured to improve over
time with input from clinicians, patients and other stakeholders”, (CMS, 2017).
Specific to the goals of this project, the scope of policy interpretation was limited
specifically to the Quality Payment Program. As a medical device company with
strategic goals to align with healthcare delivery systems and providers, Medtronic’s
focus with MACRA is relevant in the areas of improving health outcomes and reducing
cost. Therefore, further refinement of scope narrowed the policy interpretation to
specifically the Merit Based Incentives Program (MIPS) under the QPP. There are four
weighted categories within MIPS that determine the impact to physician payment, based
on scores achieved within each category (CMS, 2017). These categories are: 1)
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Clinical Practice Improvement Activities, 2) Advancing Care Information, 3) Cost and 4)
Quality. Relative to the CY 2018 updates, the percent weighting of cost will be 10% in
the 2018 performance year and will increase to 30% in the 2019 performance year,
(CMS, 217).
Data Collection
Data collection was conducted throughout the duration of the Service Learning period.
Surveys were distributed utilizing the Qualtrics evaluation tool. These surveys were
distributed to attendees of the Medical Director and Economic Value Advisory Panel
(MDAP) and the Hospital Administrator’s Advisory Meeting (HAAM). Each survey
audience represented a key stakeholder group and provided a diversity of perspectives
and backgrounds.
Panelists from the MDAP group represented the payer’s perspective and provided
insight and consultation related to value initiatives. The panelists all had significant
experience in managing either large hospital systems, governmental health
organizations, or insurance companies. All panelists were physicians, and 50% of the
panel also held MBA or MPH degrees, (Medtronic, 2017). Throughout the meeting,
panelists were presented with various value initiatives from across all Medtronic
business units, after which the panelists provided critical, objective feedback. Many
themes emerged from the 3-day meeting and were collected as part of the MDAP Key
Learnings report, (Medtronic, 2017). One important message that carried through the
meeting was “value is relative to stakeholders”, (Medtronic, 2017).
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MDAP Themes (Medtronic, 2017):
• Priority of Clinical Evidence
•

Long-term clinical data is key

•

Innovation must be accompanied by clinical value

•

Value is relative to stakeholders

Panelists from the HAAM group represented a different set of stakeholders, which were
hospital administrators and service line directors. This audience was geographically
diverse (25 participants, representing 18 U.S. states). This group was much closer to
healthcare delivery, relative to the panel of payer representatives. Additionally, this
group had a strong awareness of how transitioning from fee-for-service to outcomesbased care would impact their delivery organizations, as well as physician payments.
The goals and objectives for HAAM were outlined in relation to value-based initiatives
and the impact that specific initiatives within different business units of Medtronic would
potentially impact hospitals and physicians.
HAAM Value-Based Partnership Objectives (HAAM, 2017):
•

Understand Hospital Administrator’s focus on MACRA

•

Understand the relevant rationale for Value-Based Healthcare

•

Understand if Medtronic’s approach to VBHC is compelling

•

Understand incremental value of programs, contrasted with operational and
implementation considerations

•

Obtain feedback on current VBHC initiatives

The survey results overall were consistent, but had some variation relative to
organizational size, structure and geography. Survey questions included a broad range
of topics related to healthcare reform, understanding of MACRA/QPP, relationship of
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health systems to payers, structure/integration of physician services (example: are they
contracted groups or hospital employees?), utilization of remote monitoring or telehealth
and utilization of EHR.
Figure 1: Survey Outcomes – Hospital Administrator Advisory Meeting

The current Fee For Service system
Is definitely changing and we are actively
taking steps to adapt.
Is eventually changing thus we are keeping
aware, but not making changes at this
time.
Will never truly change, thus we are not
partiicpating in bundles, ACOs or valuebased purchasing.
0

5

10

*Medtronic, (2017). Hospital Administrator Advisory Meeting: Final Report.
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Figure 2: Survey Outcomes – Hospital Administrator Advisory Meeting

Our system has made the following decision
regarding aligning closely with one or more
payers:
We have no plans to align in a partnership
with a payer
We are open to aligning closely with a payer,
but have no formalized partnership.
We have recently aligned with a payer in the
past 2 years.
We have been aligned closely with a payer
for 2+ years
0

2

4

6

8

10

*Medtronic, (2017). Hospital Administrator Advisory Meeting: Final Report.

Figure 3: Survey Outcomes – Hospital Administrator Advisory Meeting

Have you signed a risk share
agreement with a vendor?

Yes (13)

No (10)

*Medtronic, (2017). Hospital Administrator Advisory Meeting: Final Report.
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12

14

Gap Analysis
The gap analysis process began with Medtronic’s Value-Based Healthcare (VBHC) core
value of providing economic value across all business units and leveraging its
leadership in biomedical innovation to advance the role of technology in “improving
clinical outcomes and maximizing efficiencies across the care continuum”, (Medtronic,
2015). Utilizing the strategic objectives that align to this goal the analysis framework
was designed around defining the current standing of these objectives, identifying
deficiencies and developing an action plan. VBHC extends far beyond the MACRA
legislation into many clinical and therapy areas of Medtronic’s large business structure.
However, the focus of this analysis was narrow and specific to the impact of MACRA
and QPP. Within the scope of this project, three key areas were identified as gaps
related to the understanding of MACRA and QPP by internal and external customers.
Stakeholder interviews were the primary source of data for the analysis. The most
significant finding in the gap analysis was the inconsistent application of education
across various business units within the company.
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Table 2: Gap Analysis Results
Strategic Objective

Evolve value-based
healthcare
Leverage
technologies
Develop solutions
Integrate health
systems
Align value among
stakeholders

Current Standing

Deficiency

Action Plan

“The attempts to
move towards valuebased models are
only
in the early stages,
and many systems,
payers, and
governments are just
beginning to learn
how to implement
value-based care
model”,
(Medtronic, 2016).

Aligning value
requires in-depth
perspective from
each stakeholder
group, which is not
consistent.
Internal
-Business units
-Field Sales
External
-Providers
-Payers
-Hospital
-Systems

Identify gaps
Prioritize level of
urgency
Select areas of focus
with highest ROI

Individual BU’s have
education/training, with
specific examples of
QPP/MIPS impact

-Examples and impact
are not uniform or
transferrable across
BU’s

-Develop supplemental
educational slides
focused on MIPS Cost
Component

-Competitors have
educational programs
that mirror CMS

-Webinar for external
audience

Physician engagement
primarily occurring at
the regional level

-General physician
awareness of
program/impacts is
variable
-Physician business
structure drives
engagement (hospitalemployed, private
practice, multi-specialty
group)

Engage with specialty
physician societies:
-segment information
-align on
recommendations
-communication and
implementation plan

Monthly healtheconomics leader calls
(cross-business unit)

Variable benchmarks in
QPP quality measures,
whose impact varies
dependent on business
unit
(ex: cardiovascular
versus diabetes)

Utilize/update
Medtronic Health
Economics data library
to share case examples
across business units,
as well as general, panMedtronic QPP
education material

GAPS
Comprehensive
overview of QPP:
Business-Unit neutral

GAPS
Understanding of how
specific physician
specialties are
selecting quality
measures within QPP

GAPS
Impact of MACRA on
individual
Business Units

Page | 21

SL/CE Final Paper – Katie Joseph Johnson

Program Development
Results from the program development segment of this project were aligned to the
defined research questions stated in the SL/CE proposal phase. Findings for each
question varied by their ability to influence the outcomes. Some factors were tangible
and easier to prioritize, whereas others were not areas where Medtronic could provide a
solution. Additional details from program evaluation steps can be found in Appendix B,
Table 3.
What training and education is needed for care providers to understand the impact and
implications of the 2018 Updates to the MACRA legislation on physician payment
models?
•
•
•

Comprehensive, consistent, basic overview of MACRA, QPP and MIPS
Physician specialty-level examples of implementation and best-practices
Recurring webinars

What factors are driving the decision of providers to choose one facet of the QPP over
the other (MIPS versus APMS)?
•
•
•
•

Awareness of the program
Physician specialty type
• focus on procedural outcomes versus long-term follow-up
Business arrangement
• private practice, multi-specialty, hospital owned, accepting Medicare
Time
• impact from early reporting years

How can the medical technology industry partner with healthcare providers to ensure
value and reduced healthcare costs?
•
•
•

Partner with specialty physician societies to develop value models
Adopt existing economic modeling tools throughout business units
Facilitate stakeholder engagement with Advisory Boards
• Payer
• Hospital Administrator
• Physician
• Specialty Societies
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KEY LEARNING
Discussion
Medtronic maintains a collaborative and partnership-based approach with external
customers. This is apparent in many aspects of the business, but with this project, it
becomes evident in the comprehensive research that is dedicated to understanding how
QPP (and MIPs in particular) will impact various physician groups, dependent upon how
the individual provider is structured (for example: hospital employee versus private practice
versus multi-specialty group). The Health Economics team has been very strategic in
how/when they will present educational materials and events to these customers, as a
hasty roll-out would compromise the consultative approach that Medtronic seeks to
present.
The importance of identifying and understanding the perspectives of key stakeholders
cannot be understated with regards to QPP, as well as value-based healthcare in general.
The diverse collection of input gathered through the advisory panels, interviews and
surveys all shared this common perspective, that value is defined by the stakeholder. As it
relates specifically to value-based healthcare initiatives at Medtronic, value is provided to
the patient as a direct clinical benefit from the medical technology that impacts their
disease state. From the hospital payer and provider perspectives, value is not always
consistently defined and applied. The definition and application of value lies in the cost of
the technology, procedure and follow-up, weighed against the cost-savings or risk
avoidance provided by medical innovation, also referred to as improved outcomes,
(Pendleton, 2018). Medtronic, which provides the innovation and technology component,
defines value as:
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“…an effort to develop and deploy products, services,
and integrated solutions that improve patient outcomes per dollar
spent by the healthcare system by improving the quality of care
and/or reducing the associated expense. Solutions that fit into valuebased care typically are characterized by business models in which
payment is based on the value created by the
solution (e.g., gain-sharing arrangements), or in which payment is
contingent upon improved outcomes (e.g., services provided with a
guarantee or reduced payment for poor quality)”, (Medtronic, 2016).
As Medtronic’s Health Economics team moves forward with more educational initiatives for
customers around QPP and other value-based proposals, it will be imperative to maintain
a clear delineation of which stakeholder(s) will be impacted and to align value through that
specific lens.
Figure 4 – Identifying Key Stakeholders
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This program evaluation revealed that although Medtronic has a strong VBHC foundation
and an extremely skilled corporate Health Economics team, the individual business units
within the organization at times are challenged to find a consistent message on how
MACRA and QPP are impacting the business. An influencing factor in this challenge is the
vast of diversity among the individual business units and the disease states and medical
technology solutions they represent (Medtronic, 2018). For example, diabetes
management may focus on long-term follow-up outcomes with primary care (12-month
outcomes), whereas a cardio-thoracic surgeon who performs surgical implantations of
cardiac devices may be more focused on short-term outcomes (30-days post discharge).
As this relates to the cost components of the Merit Based Incentives Program (MIPS),
there is inconsistency between the two example business units, as the focus of QPP is
uniformly relevant to both. Further definition and context for this example can be found in
Figure 5 and Figure 6 (Appendix B), which are excerpts from the supplemental educational
materials that were developed as part of the Service Learning component.
Figure 5 - MIPS: Medicare Spending Per Beneficiary Versus Total Per Capita Cost
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Recommendations
The gap analysis identified three key areas where improvements could be made in helping
business units better align to the corporate strategic goal of providing economic value, as it
relates to understanding MACRA and QPP. The following recommendations provide
support to each area, keeping in mind the standards outlined in Public Health Program
Evaluation Framework, (CDC, 1999). Program evaluation recommendations are outlined
in 4 key areas: build, share, ensure and strengthen.


Build…strategic partnerships with key stakeholders, value models that align with
Medtronic’s strengths and capacity



Share…education, training, best practices and examples of success



Ensure…internal and external customers understand the value models for each
business and how MACRA and QPP may fit into these models



Strengthen…existing models and leverage them throughout the business units

Share, Strengthen - Medtronic’s Health Economics team have skilled and experienced
professionals developing economic models across the organization. However, not all
business units take the same approach to how this information is presented and applied to
external customers. One business unit was identified to have a highly developed
organizational structure and model for educating and engaging with customers (Figure 6).
A recommendation for addressing the identified gap of “impact of MACRA/QPP on
individual business units” would be to leverage successful programs (ex., Regional
Economics Manager), tools (ex., economic modeling tool) and best practices across all
business units.
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Figure 6 – Successful Economic Model

*Medtronic, (2017). CRHF Health Economics, Reimbursement and Policy.
Build, Share, Ensure - A second recommendation is for further leverage of Medtronic’s
partnership with the Harvard Business Review. This partnership was developed to
create synergy, awareness, collaboration and innovation to “align value, improve
outcomes and accelerate value-based healthcare”, (Medtronic, 2018). The program
includes Harvard Business Review articles and publications, webinars with leading
healthcare experts and facilitated forums. Building upon this existing program,
discussion and education around MACRA and QPP could be developed and delivered
to a diverse audience.
Build, Share, Strengthen – A common theme that emerged from stakeholder interviews
was the need for strategic engagement with physician specialty societies. Additionally,
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much of the peer-reviewed articles related to MACARA and QPP are specific to
physician specialties and how payment structures will change based on the types of
service and follow-up related to that specific specialty, (Apte & Patel, 2016), (Manchikati
et al., 2016) and (Hirsch et al., 2017). Medtronic has a demonstrated history with
conducting stakeholder advisory panels, such as MDAP and HAAM, and could benefit
from leveraging these same types of advisory panels with physician specialty societies
such as the Heart Rhythm Society, the American College of Cardiology, the American
Academy of Clinical Endocrinologists and the American Academy of Neurology. These
are a few examples of specialty societies that align with various business units within
Medtronic that could provide critical stakeholder feedback as well as provide
recommendations for value-based partnerships that could potentially improve the
outcomes of physician payment reform through the QPP and align with selected
outcomes measures for that specialty.
Conclusion
The Scope of value-based initiatives within Medtronic has a much further reach than
MACRA and the Quality Payment Program. As one facet of the transition from fee-forservice to a more outcomes-focused payment structure, QPP is an important focus for
Medtronic, but not necessarily where it can make the most impact. There are many
variables and factors that are outside of Medtronic’s scope of influence. For example,
much of the literature and stakeholder feedback cites that a key component of how QPP
will be adopted is simply time. The QPP program reporting period has only recently
begun, and many physicians and physician groups will not fully understand the impact
of this program until the full implementation of cost adaptations have had time to
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materialize in the coming two years, (Medtronic, 2017), (Apte & Patel, 2016),
(Manchikati et al., 2016) and (Hirsch et al., 2017).
“While pay for performance/value-based incentives under Medicare are not new,
MACRA created the Quality Payment Program, which provides new and significant
incentives to improve quality of care and improve coordination and efficiencies”, (Cohen
et al., 2017). Through its history with and dedication to VBHC, Medtronic has
demonstrated that the areas of cost reduction and quality outcomes are where its
technology, tools and resources can make the most impact. Continued focus on cost
reduction and quality outcomes will have the most impact in providing economic value
to customers, and while MACRA and QPP may not be the primary objectives of this
focus, they do filter into outcomes and cost.
The conclusions of this program evaluation of the educational offerings of Medtronic’s
Health Economics team indicate that this program is comprehensive, informed and
provides customers with valuable, applicable information. Continuing to build on this
program and increase the adoption of successful models and best practices will further
strengthen Medtronic’s leadership position in the transition to value-based healthcare.
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APPENDIX A: Application of Public Health Competencies

Core/Cross-Cutting Domains
Competency, Activity/Application1, 2

Reflection of Competency Strength/ Professional Growth3

Committee
Assessment4

Competency 4.A: Health Policy and Management: Identify the main
Reflection:
components and issues of the structure, financing, and delivery of health This was as skill that I had begun to develop during my concentration courses during my
services within the health systems in the U.S.
MPH, and further strengthened this skill during the SL/CE, particularly during the policy
analysis and literature review phases. I feel that I am competent at this skill but will benefit
Activity/Application: Conduct legislation and policy review of MACRA, QPP, from further development.:
and Proposed Changes for 2017

Not Competent

Competency 8.A: Leadership, Advocacy and Community-Building: Identify Reflection:
linkages with key stakeholders.
Through the process of key stakeholder interviews and participating in advisory meetings,
my ability to link with stakeholders was further developed. As a part of my current role as a
strategist, this was a skill I already possessed and was highly competent in
Activity/Application: Conduct interviews with key stakeholders

Not Competent

Competency 8.C: Engage in collaborative problem-solving and decision
making.

Not Competent

Activity/Application: Develop supplemental training materials to support
policy implementation with Healthcare Economics team

Reflection:
During the collaboration process with health policy analysists I was able to engage in problem
solving to develop materials related to MIPS that brought a creative approach to existing
material. This is also a skill I possessed as a strategist, but I was able to apply it to a
completely different content area through this project.

Somewhat Competent
Competent
X Highly Competent
Uncertain

Somewhat Competent
Competent
X Highly Competent
Uncertain
Somewhat Competent
Competent
X Highly Competent
Uncertain

Overall Assessment of Core/Cross-Cutting Domains (completed by Committee Chair with input from Committee Members)4
Comments regarding student’s progress and professional growth in the above core competency areas, including current strengths/weaknesses:

1

Insert additional rows as needed for the number of competencies addressed, as described above.
Compete this column with the proposal, update as needed for final paper
3
Complete this column when writing the final paper and submit completed competencies with the final paper
4
Committee Chair, with input from Committee members will complete the evaluation at the completion of the project
2

Concentration Domains
Competency, Activity/Application1, 2

Reflection of Competency Strength/ Professional Growth3

Competency 2.C: Evaluation of Programs and Interventions: Apply
evaluation findings to programs and policies.
Activity/Application: Conduct a program needs analysis related to
the impact of QPP legislation changes on Medtronic’s Value Based
Health Care training/education initiatives.

Reflection:
Using the CDC’s Six Step Program Evaluation Framework was a new experience for my in realworld application. Until using the framework for this project, I had only used it theoretically
during my Program Evaluation course for my concentration. I would rate my level of skill in this
area as somewhat competent and an opportunity for further growth.

Competency 3.A: Strategic Planning: Evaluate and document internal Reflection:
and external strengths, weakness, opportunities and threats to
The gap analysis provided me an opportunity to practice my abilities in this area. It is also a skill I
identify strategic issues.
utilize as a strategist in my current role and I would assess myself as highly competent at
identifying strengths and weaknesses for strategic issues
Activity/Application: Attend and observe physician panel, Healthcare
Economics Advisory board meeting and Hospital Administrator’s
Advisory Board meeting to gain internal and external perspectives on
key issues
Competency 3.C: Strategic Planning: Demonstrate the skills to lead
and facilitate planning activities.
Activity/Application: Provide planning and logistical support to
healthcare economics and hospital administrator’s advisory board
meeting (MDAP) to strengthen skills related to planning and
facilitation

Reflection:
The planning and logistical support provided to the MDAP team strengthened my existing skills in
this area, particularly due to the nature of the content, material and focus. My planning and
facilitation skills were related to clinical and technical education, so this brought a new insight to
these skills.

Committee
Assessment4
Not Competent
Somewhat Competent
Competent
X Highly Competent
Uncertain
Not Competent
Somewhat Competent
X Competent
Highly Competent
Uncertain

Not Competent
Somewhat Competent
X Competent
Highly Competent
Uncertain

Competency 3.D: Strategic Planning: Demonstrate the skills to
Although I do have some experience in this area, implementing strategic plans is also an area of
implement operational and strategic plans, evaluating performance continued development and growth for me.
and adjusting implementation activities and/or plans

Not Competent

Activity/Application: Develop a comprehensive education/training
plan

Highly Competent

Assessment of Concentration Competencies (completed by Committee Chair with input from Committee Members)4
Comments regarding student’s progress and professional growth in the above concentration competency areas, including current strengths/weaknesses:
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Somewhat Competent
X Competent
Uncertain

APPENDIX B: Additional Tables and Figures

Table 3 – Program Evaluation Outcomes (CDC’s Six Step Framework)
Evaluation
Step

Service Learning Activity


Engage
stakeholders

Describe the
program






Hospital Administrator’s Advisory
Panel
Medical Director and Healthcare
Economics Panel
Health Economics team conference
calls
Policy analysis
Education database and materials
review

Standards Applied
Utility
(Serve the information needs of
intended users)

Feasibility
(Be realistic, prudent, diplomatic,
and frugal)

Utility
Feasibility
Feasibility

Focus
evaluation
design



Gap analysis

Gather
credible
evidence




Surveys
Stakeholder interviews

Propriety
(Behave legally, ethically, and
with regard for the welfare of
those involved and
those affected)

Utility

Feasibility

Justify
conclusions



Ensure use
and share
lessons
learned
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Align recommendations to Defined
Research Questions

Distribute findings through
appropriate organizational channels
Internal and external customers
Consistency through business units
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Accuracy
(Reveal and convey technically
accurate information)

Propriety
Accuracy

APPENDIX B (continued)
Figure 6: MIPS – Outcomes Comparison
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SERVICE LEARNING AND CAPSTONE EXPERIENCE REFLECTION
Describe the experience with the placement site.
-What did you learn about the organization?
Medtronic has a very methodical approach to utilizing outside feedback to improve
processes, policies, and methods related to design of products and/or reimbursement
strategies. It operates in this manner to ensure relevance in the market and as a form
of risk-management. Medtronic understands the consultative value of garnering candid
feedback from external experts to have a balanced perspective on customer and
stakeholder needs.
A common theme that I have learned throughout this project is that Medtronic is
extremely methodical when formulating strategies that align with VBH concepts. There
is a strong desire from the field organization to have a “one size” approach to VBHC
(such as a common message or strategy), but the Health Economics team has resisted
this approach, to ensure a tailored and customized solution that is driven at the
business unit, or even therapy level. This is a much more detailed and time-consuming
approach, but ultimately has the most value for providers, health systems and patients.
What I noticed during the MDAP meeting, is that the Health Economics team’s senior
leadership kept the conversation closely aligned to strategic objectives. The leadership
team demonstrated strong skills related to moderating the conversation and could
answer questions posed by the expert panelists on the spot, with quick recall and
detailed understanding of the subject matter. Another management skill that was
displayed during the MDAP meeting was delegation. The host of the advisory panel
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had clearly assigned talented individuals to various aspects of the meeting and allowed
each team member to contribute effectively.
I observed strong leadership/management skills as demonstrated by my preceptor
throughout this project. As an example, she had received been receiving calls and
inquiries expressing the need for external training materials from a variety of sources. In
response, she organized a collaborative call that included the appropriate participants from
a variety of business units. The nature of the call was to determine if there was cross-over
between the needs of each business, and if a combined approach would leverage
strengths from each business unit to develop a comprehensive set of materials that would
align the message and provide consistency. The foundation of this idea was that it would
be beneficial to have a standard set of materials to draw from, rather than a fractional and
disjointed approach. A strong leader understands how to leverage the strengths of various
team members and advocates for collaboration of efforts.
-What was different than what you expected when you started the project?
In the early development of the project topic and scope (specifically QPP), I anticipated
that there would be more tangible outcomes for how Medtronic could interact with
various facets of QPP. However, what I learned is that this program is multi-factorial
and there are limited ways in which Medtronic might influence outcomes.

Describe how SL/CE activities were performed:
MDAP program support and survey development - My role and responsibilities during
the MDAP program aligned closely with my skills. Working with a cross-functional team
leveraged my communication skills. Assembling the pre-read materials for panelists
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and presenters required strong organizational skills and adaptability to ensure the
requested deliverables were accurate and complete. Also, I had to utilize critical
thinking skills to design, develop and distribute the post-meeting surveys.
Spending 3 days immersed in the Medical Director’s Advisory Panel was a rich
educational experience, as it provided first-hand accounts of how Medtronic develops
value-based health care initiatives, and how hospital administrators and payors
respond/react to these ideas. Many of the programs targeted cost savings, expanded
access of therapies, or risk-sharing. The panelists provided candid feedback, which
was not always positive towards the projects and programs. However, this was critical
to the nature of the meeting, in that various Medtronic business units wanted to identify
challenges before releasing these programs to the market. Assembling and organizing
the pre-meeting materials gave me access to many different projects across the whole
Medtronic organization. This high-level perspective provided me with a stronger
understanding of how Medtronic applies health economic principles and engages with
many different types of stakeholders (care providers, hospital administrators, payors,
CMS, etc). Twelve (12) common themes emerged from the post-meeting debrief
sessions, of which I will share several that stood out to me (generalized and deidentified to maintain integrity of business-confidential material):
1. Payers still expressed willingness to pay for true innovation and clinical value.
2. Clinical evidence continues to be most important, even with evidence of good
economic value.
3. Payers also expect to see 3-5 years of long-term clinical data
4. What might be value for a patient or a provider might not translate into value for a
payer.
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Development of educational materials - Supplemental slides were developed for an
existing presentation. These were intended for external physician/provider customers, but
the draft materials were piloted to an internal, field-based audience to evaluate their impact
and effectiveness prior to delivering them to an external audience. This would be one
example of how Medtronic achieves a consultative approach and has a distinctly different
strategy for customers versus internal audiences. Additionally, a learning transcript and
quiz were developed from an expert physician panel discussion web-cast which was
developed into an on-line learning module for both internal and external customers.
Gap analysis - Conducting the program needs/gap analysis required gathering
information, perspectives, current state, desired outcomes, assessing completeness of
stakeholders (were all the appropriate stakeholders accounted for?), interpretation of
findings and development of an evaluation. I needed to apply critical thinking to
determine how to best translate the “desired state” (as expressed by the Health
Economics Analyst) into a scenario-based matrix that would adequately represent and
convey the information. Conducting interviews with various experts in the field of Value
Based Healthcare was a very in-depth process that required researching each role.
This was to ensure that the interview questions were appropriate for the context and
would yield the types of answers that would be most useful. A common theme that I
identified through the various interviews was that reimbursement issues are vastly
different among business units/therapy groups. This means that Medtronic as a
company cannot apply a one-size-fits-all approach to VBHC policies, as each business
unit has very specific needs.
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Describe your key learnings and final reflections.
- What were the greatest challenges of your Service Learning/Capstone Experience?
How did you address and overcome those challenges?
Towards the end of my Service Learning period, one of the needs changed related to a
deliverable for my placement site. We had spent time planning and developing a
Specialty Physician Society Advisory Panel, which was to take place in early Spring
(April), but it has been postponed to after my SL/CE is complete (summer or early fall).
Therefore, some of my hours have been achieved on this project, but my preceptor
quickly identified another area where my skills and Service Learning hours could be
achieved. This demonstrated agile thinking and adaptability by my preceptor and
allowed me to have a continuous and valuable learning experience, while also providing
the service that they needed. This also posed challenges related to my final paper and
presentation, as the outcomes of the advisory board were intended to be included in the
results. However, I adapted my paper and presentation to reflect that rather than a
“deliverable”, this activity became part of the “recommendations” section as an outcome
of the program evaluation.
-What skills were developed or strengthened during this experience?
One skill I demonstrated during this project was the ability to translate written and verbal ideas into
tangible presentation materials. During one of my calls with the Health Economics Analyst, she
expressed that she was very strong at technical writing and essays but was struggling to convert
these ideas into presentation materials. I could take her vision and create a scenario-based matrix
that allowed her ideas to become case-studies. This was a much more consumable approach to
presenting the material, rather than a long essay.
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My understanding of how to review and interpret legislation and policy was significantly
strengthened during this period, both from self-study and review, as well as
disseminating the information with the Health Economics Analyst that I am working with
on this project. It has been very valuable as a learning experience to be able to verbally
express my interpretation of the law, and then get feedback and correction from an
expert. During the development of my proposal, I made certain assumptions based on
the reading, and to have the ability to clarify those concepts with an expert was an
enriching experience (benchmarks, MIPs reporting for Tax ID # rather than group-level
practice, definitions of MSPB and TCPP etc).

The Service Learning experience of working with the Health Economics Team at
Medtronic provided many critical learning experiences and the opportunity to both
observe as well as directly contribute to the team. Existing skills were strengthened,
and new skills were developed. I was able to work with a variety of individuals as well
as teams, which provided a diverse learning environment. The culture of Medtronic as
a company is rooted in a patient and clinician-centered approach to decision making,
and this was evident within the Health Economics Team specifically. There was a
strong sense of problem-solving and ensuring quality outcomes for patients and
clinicians which provided a driving force for the various projects and programs I was
involved in during this Service Learning and Capstone Experience. The Health
Economics Team works tirelessly to ensure their team has an expert understanding of
health policy, reimbursement, risk-sharing, cost-sharing, outcomes measures, private
payor perspective, and Medicare perspectives. These areas must also be understood
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within the context and detail of each individual business unit within Medtronic. One
facet of this experience that I did not expect was how these various layers of complexity
can be barriers to progress with projects. For example: One business unit within
Medtronic may be able to apply specific QPP measures to a specific therapy, whereas
the same QPP measure might have a negative impact on a therapy in another business
unit. This makes a significant challenge in having a singular, consistent strategy for
health economic policy across business groups.
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